Prothena Corp PLC (PRTA)
49.00
+0.88 (+1.83%)
USD |
NASDAQ |
Mar 29, 12:38
Prothena 1 Year Total Returns (Daily): 30.19% for March 28, 2023
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
March 28, 2023 | 30.19% |
March 27, 2023 | 29.47% |
March 24, 2023 | 24.43% |
March 23, 2023 | 32.42% |
March 22, 2023 | 24.42% |
March 21, 2023 | 30.43% |
March 20, 2023 | 22.93% |
March 17, 2023 | 29.69% |
March 16, 2023 | 37.13% |
March 15, 2023 | 47.10% |
March 14, 2023 | 51.72% |
March 13, 2023 | 44.80% |
March 10, 2023 | 41.08% |
March 09, 2023 | 47.49% |
March 08, 2023 | 71.70% |
March 07, 2023 | 71.79% |
March 06, 2023 | 74.44% |
March 03, 2023 | 66.86% |
March 02, 2023 | 58.40% |
March 01, 2023 | 67.46% |
February 28, 2023 | 61.16% |
February 27, 2023 | 54.50% |
February 24, 2023 | 57.66% |
February 23, 2023 | 56.86% |
February 22, 2023 | 52.56% |
Date | Value |
---|---|
February 21, 2023 | 52.57% |
February 17, 2023 | 52.37% |
February 16, 2023 | 40.96% |
February 15, 2023 | 43.90% |
February 14, 2023 | 52.98% |
February 13, 2023 | 51.96% |
February 10, 2023 | 48.36% |
February 09, 2023 | 49.71% |
February 08, 2023 | 59.01% |
February 07, 2023 | 64.78% |
February 06, 2023 | 72.81% |
February 03, 2023 | 78.46% |
February 02, 2023 | 69.72% |
February 01, 2023 | 54.85% |
January 31, 2023 | 65.93% |
January 30, 2023 | 68.12% |
January 27, 2023 | 81.62% |
January 26, 2023 | 65.58% |
January 25, 2023 | 61.03% |
January 24, 2023 | 57.60% |
January 23, 2023 | 56.40% |
January 20, 2023 | 53.99% |
January 19, 2023 | 49.34% |
January 18, 2023 | 47.93% |
January 17, 2023 | 41.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.69%
Minimum
Sep 28 2018
679.5%
Maximum
Sep 23 2021
44.02%
Average
2.38%
Median
1 Year Total Returns (Daily) Benchmarks
Mallinckrodt PLC | -- |
Jazz Pharmaceuticals PLC | -9.83% |
Nabriva Therapeutics PLC | -85.62% |
Iterum Therapeutics PLC | -83.50% |
GH Research PLC | -58.50% |